cbdMD, Inc. (YCBD) Earnings Call Transcripts

25 earnings calls from February 2020 to May 14, 2026

NYSEAM US Health Care Pharmaceuticals

About cbdMD, Inc.

cbdMD, Inc. (YCBD) is a publicly listed company in the Pharmaceuticals industry, within the Health Care sector. It trades on NYSEAM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 25 calls on record spanning February 13, 2020 to May 14, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 25 cbdMD, Inc. earnings call transcripts on record, spanning February 13, 2020 to May 14, 2026. Based on this history, cbdMD, Inc. reports quarterly. The most recent call on file is dated May 14, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
YCBD
Exchange
NYSEAM
Country
US
Sector
Health Care
Industry
Pharmaceuticals
Calls on record
25
First call
February 13, 2020
Most recent
May 14, 2026
Reporting cadence
quarterly
Quarter Date
Q2 FY2026 May 14, 2026 Read transcript
Q1 FY2026 Feb 17, 2026 Read transcript
Q4 FY2025 Dec 19, 2025 Read transcript
Q2 FY2025 May 15, 2025 Read transcript
Q1 FY2025 Feb 13, 2025 Read transcript
Q4 FY2024 Dec 18, 2024 Read transcript
Shareholder/Analyst Calls Mar 29, 2024 Read transcript
Q3 FY2023 Aug 10, 2023 Read transcript
Q2 FY2023 May 15, 2023 Read transcript
Shareholder/Analyst Calls Feb 16, 2023 Read transcript
Q1 FY2023 Feb 13, 2023 Read transcript
Q3 FY2022 Aug 11, 2022 Read transcript
Q2 FY2022 May 13, 2022 Read transcript
Shareholder/Analyst Calls Mar 11, 2022 Read transcript
Q1 FY2022 Feb 10, 2022 Read transcript
Q4 FY2021 Dec 17, 2021 Read transcript
Q3 FY2021 Aug 12, 2021 Read transcript
Q2 FY2021 May 12, 2021 Read transcript
Shareholder/Analyst Calls Mar 12, 2021 Read transcript
Q1 FY2021 Feb 9, 2021 Read transcript
Q4 FY2020 Dec 22, 2020 Read transcript
Q3 FY2020 Aug 12, 2020 Read transcript
Q2 FY2020 May 18, 2020 Read transcript
Shareholder/Analyst Calls Apr 23, 2020 Read transcript
Q1 FY2020 Feb 13, 2020 Read transcript